Related Experiment Video
Updated: Jul 12, 2025
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Chronic hyperkalemia, diagnosis and management. Colombian consensus
Jorge Rico-Fontalvo1, María J Rodríguez-González2, Erica Y Yama3
1Departamento de Nefrología, Nephromedicall IPS, Medellín, Antioquia.
Insights
This consensus provides recommendations for managing chronic hyperkalemia, a condition of elevated serum potassium. Key strategies include controlling risk factors and optimizing treatment for patients with kidney disease, heart failure, or diabetes.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic hyperkalemia is defined by recurrent elevated serum potassium levels (mild: 5.0–5.5, moderate: 5.5–6.0, severe: >6.0 mEq/L).
- Risk factors include chronic kidney disease, heart failure, diabetes, advanced age, hypertension, and renin-angiotensin-aldosterone system inhibitors (RAASi).
- Current management lacks consensus, necessitating evidence-based guidelines.
Purpose of the Study:
- To generate recommendations for the diagnosis, management, and follow-up of chronic hyperkalemia.
- To provide a structured approach for clinicians dealing with this condition.
Main Methods:
- A consensus statement developed by nephrologists and cardiologists.
- Adherence to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology.
Main Results:
- Identified key risk factors for chronic hyperkalemia.
- Outlined a management strategy involving risk factor control, dietary advice, RAASi optimization, potassium binder administration, and metabolic acidosis correction.
- Emphasized the need for careful diagnosis and follow-up, particularly in high-risk populations.
Conclusions:
- Highlights the importance of proactive diagnosis, management, and follow-up of chronic hyperkalemia.
- Recommends specific interventions for patients with identified risk factors.
Objective:
Generate recommendations for the diagnosis, management, and follow-up of chronic hyperkalemia.
Method:
This consensus was made by nephrologists and cardiologists following the GRADE methodology.
Results:
Chronic hyperkalemia can be defined as a biochemical condition with or without clinical manifestations characterized by a recurrent elevation of serum potassium levels that may require pharmacological and or non-pharmacological intervention. It can be classified as mild (K+ 5.0 to < 5.5 mEq/L), moderate (K+ 5.5 to 6.0 mEq/L) or severe (K+ > 6.0 mEq/L). Its incidence and prevalence have yet to be determined. Risk factors: chronic kidney disease, chronic heart failure, diabetes mellitus, age ≥ 65 years, hypertension, and drugs that inhibit the renin angiotensin aldosterone system (RAASi), among others. There is no consensus for the management of chronic hyperkalemia. The suggested pattern for patients is to identify and eliminate or control risk factors, provide advice on potassium intake and, for whom it is indicated, optimize RAASi therapy, administer oral potassium binders and correct metabolic acidosis.
Conclusions:
The recommendation is to pay attention to the diagnosis, management, and follow-up of chronic hyperkalemia, especially in patients with risk factors.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
01:20Acute Kidney Injury V: Interprofessional Care
01:18Chronic Kidney Disease IV: Nursing Management
01:22Acute Kidney Injury VI: Nursing Management
01:25Dysrhythmias VI: Management of Dysrhythmias
01:29Cardiomyopathy V: Interprofessional Care